James Brunk
Analyst · Barclays. Your line is now open
Thank you, Jeff. Sales for the quarter exceeded $2.8 billion, a 9.4% increase as reported and 8.7% on a constant basis. All segments showed growth, primarily due to price and mix actions as volume was generally constrained by supply, labor, transportation and COVID disruptions. Gross margin, as reported, was 29.7% or 29.8% excluding charges, increasing from 28.3% last year. The year-over-year increase was driven primarily by improved price and mix, which offset the increasing rate of inflation. In addition, gains in productivity, less year-over-year downtime and favorable FX improved our margins. The actual detailed amounts of these items will be included in the MD&A section of our 10-Q, which will be filed after the call. SG&A as reported was 16.9% and flat versus prior year, excluding charges. Increased SG&A dollars versus prior year as a result of costs that were curtailed due to the COVID-19 pandemic, higher sales, increased inflation, new product development and price and mix. Operating margin as reported was 12.8%. Restructuring charges were approximately $1 million, and we have reached our original savings goal exceeding $100 million in annual savings. We continue, though, to pursue other initiatives to lower our costs. Operating margins, excluding charges, were also 12.8%, improving from 11.5% in the prior year or 130 basis points. The increase was driven by improved price and mix, offsetting increasing inflation as well as gains in productivity, favorable FX and greater year-over-year manufacturing uptime, improving our results. We were partially offset by impact of constrained volume and increased cost in product development. Interest expense was $15 million in the quarter, flat versus prior year. Our non-GAAP tax rate was 21.4% versus 16.9% in the prior year, and we still expect the full year rate to be between 21.5% and 22.5%. Earnings per share as reported were $3.93, and excluding charges were $3.95, increasing by 21% versus prior year. Now turning to the segments. Global ceramic sales came in just under $1 billion, a 9.6% increase as reported or approximately 9.1% on a constant basis, led by strengthening price and mix across our geographic regions. Brazil, Mexico and the U.S. countertop business saw the strongest volume gains while other products performed well against a difficult year-over-year Q3 comp comparison, which had an abnormal seasonality. Operating margin excluding charges was 11.9%, up 160 basis points versus prior year due to the favorable price/mix offsetting increasing inflation, which improved -- with improved productivity and limited year-over-year shutdowns strengthening our results, partially offset by increased costs in new product development. Flooring North America sales just exceeded $1 billion, a 6.9% increase as reported. The sales growth was driven by price and mix actions to offset rising costs as our sales volumes were impacted by supply, transportation and labor constraints. Operating margin excluding charges was 11.4%. That's an increase of 320 basis points versus prior year. The improvement was driven by positive price/mix offsetting the increasing inflation and volume constraints. In addition, productivity gains and less temporary shutdowns favorably impacted our results. In Flooring Rest of the World, sales exceeded $760 million, a 12.7% as reported increase or 10.5% on a constant basis, driven again by price and mix actions while volumes here were constrained by material disruptions, especially in LVT, are returned to a normal summer seasonality and COVID restrictions, which caused lockdowns in Australia, New Zealand and Malaysia. Operating margin, excluding charges, was 17.4%. This is a decrease versus prior year as a result of the return to a normal summer holiday, along with material constraints and COVID lockdowns which increased our costs and lower productivity, volume and increase the temporary shutdown. Improved price mix, which offset the increase in inflation and favorable FX benefited our results. Corporate and eliminations were $11 million, and I would expect that to be $45 million for the full year. Taking a look at the balance sheet. Cash for the quarter exceeded $1.1 billion with free cash flow of $351 million in the quarter and over $720 million in third quarter year-to-date. Receivables were just shy of $1.9 billion with a DSO of just under 57 days. Inventories were just over $2.2 billion, an increase of approximately $374 million or 20% from the prior year. That's an increase of about 16% if you compare to the year-end balance. Inventory days just under 107 days compared to our low point last year at just under 100 days and 103 days at the year-end. Property, plant and equipment exceeded $4.4 billion with CapEx for the quarter at $148 million, in line with our D&A. Full year CapEx is currently projected to be $650 million, with D&A projected at $586 million. Looking at the current debt. One note on October 19, the Company redeemed at par their January 2022 $500 million euro 2% senior notes plus unpaid interest, utilizing cash on hand. The balance sheet overall and cash flow remained very strong with gross debt as of the end of Q3 of $2.3 billion and leverage at 0.6x to adjusted EBITDA. And with that, I will turn it over to Chris to review our operational results.